Clinical Management of Rifampicin-Resistant Tubercolosis
This Updated Clinical Reference Guide is a revision of the Management of RR-TB: A Clinical Reference Guide, published in November 2019. The main changes in the document include introducing the 6-month regimens known as BPaL and BPaL-L regimens, discussion of the new inclusion and exclusion criteria, treatment modalities, treatment follow up and post-treatment follow-up.